Concepedia

Cliff C. Cheng

CC

Statistics

Publications

11

Citations

423

H-Index

11

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Cliff C. Cheng is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

2006–2013

11

Publications

11

Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity

Lan Hong, Cliff C. Cheng, Timothy J. Kowalski et al. · Journal of Lipid Research · 2011 · 85 citations · Full text

, , +14

Discovery and optimization of antibacterial AccC inhibitors

Cliff C. Cheng, Gerald W. Shipps, Zhiwei Yang et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 58 citations

, , +12

Discovery and Characterization of Orthosteric and Allosteric Muscarinic M2 Acetylcholine Receptor Ligands by Affinity Selection–Mass Spectrometry

Charles E. Whitehurst, Naim Nazef, D. Allen Annis et al. · SLAS DISCOVERY · 2006 · 49 citations · Full text

, , +17

Discovery of a Novel Series of CHK1 Kinase Inhibitors with a Distinctive Hinge Binding Mode

Xiaohua Huang, Cliff C. Cheng, Thierry Fischmann et al. · ACS Medicinal Chemistry Letters · 2012 · 45 citations · Full text

, , +17

Inhibitors of the Lipid Phosphatase SHIP2 Discovered by High Throughput Affinity Selection-Mass Spectrometry Screening of Combinatorial Libraries

Douglas S. Annis, Cliff C. Cheng, Cheng‐Chi Chuang et al. · Combinatorial Chemistry & High Throughput Screening · 2009 · 41 citations

, , +16

1–5 of 11